Collectively, these studies suggest that obesity-associated variants of FTO regulate the expression of IRX3 and IRX5 in the hypothalamus and adipose tissue contributing to metabolic changes. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.